Quinn Lu

GlaxoSmithKline (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.0kcitations47works8.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(8), Viral Infectious Diseases and Gene Expression in Insects(8), RNA and protein synthesis mechanisms(6), Genomics and Chromatin Dynamics(4), Monoclonal and Polyclonal Antibodies Research(4)

Publications47 total

Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1
Journal of Biological Chemistry·2024· 8 citedOpen Access
Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1 in HepG2 cells
2023Open Access
Commercially Available Reagents and Contract Research Services for CRISPR‐Based Studies
2022
Comparative Analysis of Multiple Immunoassays for Cytokine Profiling in Drug Discovery
SLAS DISCOVERY·2020· 51 citedOpen Access
Screen for modulators of atonal homolog 1 gene expression using notch pathway-relevant gene transcription based cellular assays
PLoS ONE·2018· 5 citedOpen Access
Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments
Journal of Biotechnology·2018· 93 cited
Correction: Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening
Nature Communications·2018· 2 citedOpen Access
A systematic approach integrating genetics, computational biology, chemical genomics and gene editing to identify novel targets in the Type I interferon signaling pathway for autoimmune and infectious diseases
The Journal of Immunology·2018
Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening
Nature Communications·2017· 74 citedOpen Access
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress
Journal of the American Heart Association·2017· 30 citedOpen Access
Applications of CRISPR genome editing technology in drug target identification and validation
Expert Opinion on Drug Discovery·2017· 20 cited
Gene Expression in Mammalian Cells Using BacMam, a Modified Baculovirus System
Methods in molecular biology·2016· 19 cited
A Luciferase Reporter Gene System for High-Throughput Screening of γ-Globin Gene Activators
Methods in molecular biology·2016· 11 cited
A High-Content Imaging Screen for Cellular Regulators of β-Catenin Protein Abundance
SLAS DISCOVERY·2015· 1 citedOpen Access
Plasmid Vectors for Gene Cloning and Expression
ASM Press eBooks·2014· 3 cited
Co-expression for intracellular processing in microbial protein production
Biotechnology Letters·2013· 3 cited
Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism
Cell Cycle·2013· 20 citedOpen Access
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase
Bioorganic & Medicinal Chemistry Letters·2013· 64 citedOpen Access
Development of a Cell-Based High Throughput Luciferase Enzyme Fragment Complementation Assay to Identify Nuclear-Factor-E2-Related Transcription Factor 2 Activators
Assay and Drug Development Technologies·2012· 16 cited
Perspectives on the Discovery of Small-Molecule Modulators for Epigenetic Processes
SLAS DISCOVERY·2012· 24 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Robert S. Ames(9), Taylor Graham(6), Wensheng Xie(6), John J. Kerrigan(5), Andrew J. Pope(4), James A. Fornwald(4), Sarah C. R. Elgin(3), Wangfang Hou(3), Svetlana Belyanskaya(3), Yun Ding(3), Jason W. Dodson(3), Christina Pao(3), Jeffrey W. Gross(3), Joseph P. Marino(3), Tanya Hosfield(3), Dayuan Wang(3), Gregory J. Gatto(3), Xiaoyan Tang(3), Zining Wu(3), Lori L. Wallrath(2)